RheumNow

A JAKi in GCA: Phase 3 Results Through 2 Years bwaits1974@gmail.com Sat, 11/01/2025 – 09:00

Sjögren’s Disease – What Are You Missing? bwaits1974@gmail.com Sat, 11/01/2025 – 09:00

#ACR25 Sheds Light on Disparities, Age-Related Trends, and Epidemiology in Autoimmune Rheumatic Diseases At #ACR25, ne https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 10/31/2025

💬 #ACR2025 Topic Panels — LIVE! Nov. 2 join RheumNow at 7 PM ET for a deep dives into the

ACR25 Best Abstracts – Day 4 jjcush@gmail.com Fri, 10/31/2025 – 15:52

Upadacitinib is a Double Edged Vascular Sword in GCA Dr. David Liew discusses abstracts O751, O738, and O734 presented https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

Halloween ACR Guidance (10.31.25) jjcush@gmail.com Fri, 10/31/2025 – 15:47

Hospitalization in Stills: Is it “Still” an infection? Dr. Janet Pope discusses abstract 0163, “Trends in hospitalizat https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,

Rheumatoid arthritis and the ‘big bang’ at #ACR25! Is there ‘bang for the buck’ using big data to help predic

RheumNow Rheumatology Round-Up https://t.co/eKcEoDEESO https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 10/31/2025 – 13:00 RheumNow Dr. John Cush RheumNow Rheumatology Round-Up https://t.co/eKcEoDEESO Dr. John

SLE Conference Preview: progress in biologics at #ACR25 We now have four licensed targeted therapies (i.e., belimumab, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,

Why I love the late breaking abstracts david.fl.liew@… Fri, 10/31/2025 – 10:47

Psoriatic Arthritis Imaging Dr. Arthur Kavanaugh talks about imaging in psoriatic arthritis at #ACR25 https://t.co/l6M https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 10/30/2025 –

Lupus in Focus: 2025 ACR Treatment Guidelines for SLE Dr. Sheila Reyes reports on the scientific session presentation https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

Where are we at with PD-1 agonism? david.fl.liew@… Thu, 10/30/2025 – 18:15

Day 1 Recap: #ACR25 Highlights Join RheumNow Faculty Drs. Aurelie Najm, Yuz Yusof, Janet Pope, and Jack Cush for Day

RheumNow’s coverage of the #ACR25 annual meeting is sponsored by Bristol Myers Squibb, Novartis, and UCB. All coverage https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

Bone Density in Ankylosing Spondylitis Drbellamehta@g… Thu, 10/30/2025 – 15:00

GLP-1 Receptor Agonists in PsA: Mortality and MACE https://t.co/GtTGHY7j5g @synovialjoints discussed TriNetX data bas https://pbs.twimg.com/profile_images/1974180952390721536/r5ej4z9M_normal.jpg john+RNV2@john… Thu, 10/30/2025 – 14:12

Why are vaccine Abs maintained after CAR-T -depletion of pathogenic #Abs are dampened/eliminated Clonal repetoire expan https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg john+RNV2@john… Thu, 10/30/2025

NEPTUNUS: Ianalumab in Sjogren’s https://t.co/K9Xm51Kb5X Finally good news in Sjogrens disease. @RheumNow #ACR25 https://pbs.twimg.com/profile_images/1974180952390721536/r5ej4z9M_normal.jpg john+RNV2@john… Thu, 10/30/2025 – 14:12 NoufAhmedAlham2

From Fitbit to first diagnosis: AI is rewriting the RA playbook Two studies presented at this year’s #ACR25 meeting h

Day 4 Recap: ACR Convergence 2025 Highlights https://t.co/CMpbzc4O5x Great discussion by @EBRheum @AkhilSoodMD @Dr_B https://pbs.twimg.com/profile_images/1974180952390721536/r5ej4z9M_normal.jpg john+RNV2@john… Thu, 10/30/2025 – 14:12

New Insights into Pregnancy Outcomes and Maternal-Fetal Health in Rheumatic Diseases At #ACR25, the ACR presented new https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,